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The nutritional and antinutritional composition of Strobilanthes 
crispus (L. ) Bremek or Saricocalyx crispus (L.) Bremek (Acanthacea) , and its 
anticancer effect during hepatocarcinogenesis were studied to investigate the 
possible cancer suppressive effect of the component existed in the leaves. The 
nutritional composition studied were of the proximate composition and 
antioxidant activity of ferric thiocyanate and thiobarbituric acid methods. 
The antinutritional factors studied were catechin, tannin, caffeine and 
alkaloid. All data were compared to Yerbamate, green tea, black tea and 
Indian tea. The leaves contained high amount of water soluble vitamins and 
total ash leading to high amount of minerals such as potassium, calcium, 
sodium, iron and phosphorus. The leaves contained low level of 
antinutritional factors contributing to better absorption of iron and water 
soluble vitamins. Its catechins showed highest antioxidant activity when 
compared to Yerbamate and Vitamin E. Consumption of the leaves extract 
daily (5 gjday) could contribute to the additional nutrient and antioxidant 
xiii 
needed in the body, especially iron. As of the in vivo study, 
hepatocarcinogenesis was monitored in rats according to Solt and Farber 
( 1 976) . The 6 - 8 weeks old ( 1 50 - 200 g) Sprague Dawley rats were treated 
with 200mgjkg diethylnitrosamine (DEN) and 0 .02% of 2-
acetylaminofluorene (AAF) without partial hepatectomy. Five percent (w jv) of 
Strobilanthes crispus extract (SeE) was used compared with 5mgj 100ml or 
0 .005% (w jv) Glycyrrhizin. The severity of neoplasia was studied by 
histological evaluations, body and liver weight profile and tumour markers. 
Histological evaluations showed loss of normal cell organization when 
carcinogens were introduced into the body. The neoplastic lesion was 
ameliorated significantly (p<0.05) with the treatment of SeE than 
Glycyrrhizin. The markers used were gamma glutamyl transpeptidase (GGT) , 
uridine diphosphoglucuronyl transferase (UDPGT) , glutathione S­
transferases (GST) , glutathione (GSH) and alkaline phosphatase (ALP) . Rats 
treated with DENj AAF had significantly (p<0.05) elevated results in all 
tumour markers except ALP, supported by body weight profile and the 
relative liver weight. SeE showed significant suppressive effect towards 
cancer cells, better than Glycyrrhizin at dosage level. Moreover, there was no 
evident suggesting side effects of SeE towards normal cells. Higher 
concentration ( 1 5  mgj 100 ml or 0.0 15%) of Glycyrrhizin is believed to 
suppress cancer more effectively than 0.005% (wjv) . 
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KOMPOSISI NUTRIEN DAN ANTINUTRlENT Strobilanthes crispus 
(L.) BREMEK DAN KESAN ANTIKANSER SEMASA 
HEPATOCARCINOGENESIS 
Oleh 
ELIZABETH MANICKAM 
Disember 1999 
Pengerusi: Profesor Madya Maznah Ismail, Ph.D. 
Fakulti: Perubatan dan Sains Kesihatan 
Komposisi nutrien dan antinutrien daun Strobilanthes crispus (L.) 
Bremek atau Saricocalyx crispus (L.) Bremek (Acanthacea) dan kesan 
antikansemya semasa hepatokarsinogenesis telah dikaji untuk menentukan 
kemungkinan kesan penumpasan kanser oleh komponen di dalam ekstrak 
daun tersebut. Komposisi nutrien yang dikaji ialah komposisi proksimat dan 
aktiviti antioksidan iaitu kaedah ferik tiosianate dan asid tiobarbiturik. 
Faktor antinutrien yang dikaji ialah katekin, tannin, kafein dan alkaloid. 
Semua data dibandingkan dengan Yerbamate, teh hijau, teh perang dan teh 
India. Daun ini mengandungi kandungan vitamin larut air yang tinggi dan 
kandungan abu yang tinggi yang menyebabkan ketinggian kandungan 
mineral seperti kalium, kalsium, natrium, ferum dan fosforus. Komposisi 
antinutrien di dalam daun ini adalah rendah yang mengalakkan penyerapan 
ferum dan vitamin larut air. Katekinnya menunjukkan aktiviti antioksidan 
yang tinggi berbanding dengan Yerbamate dan Vitamin E. Pengambilan 
harian (5 gjhari) ekstrak daun ini boleh membantu menambahkan nutrien, 
xv 
terutama zat besi, dan antioksidan yang diperlukan oleh tubuh. Kesan ke 
atas hepatokarsinogenesis in vivo pula dilakukan mengikut kaedah Solt dan 
Farber ( 1 976). Kanser pada tikus Sprague Dawley berumur 6 - 8 minggu 
( 1 50 - 200 g) diaruh dengan 200 mg/kg dietilnitrosamin (DEN) dan 0.02% 2-
asetilaminofluorin (AAF) tanpa hepatektomi separa. Lima peratus (w Iv) 
ekstrak Strobilanthes crispus (SeE) digunakan berbanding dengan 5 mg/100 
ml atau 0.005% (w/v) . Keterukan neoplastik dikaji dengan penilaian 
histologi, berat badan, berat relatif hati dan penanda tumor. Penilaian 
histologi menunjukkan kehilangan penyusunan sel-sel normal apabila 
karsinogen diaruh ke dalam badan. Lesion neoplastik didapati bertambah 
baik secara signifIkan (p<0.05) dengan pemberian SeE daripada 
Glycyrrhizin. Penanda enzim yang dikaji ialah gamma glutamil 
transpeptidase (GGT) , uridil difosfoglucuronil transferase (UDPGT) , glutation 
S-transferase (GST) , glutation (GSH) dan alkaline fosfat (ALP). Tikus yang 
diaruh dengan DEN I AAF mempunyai aras enzim penanda yang lebih tinggi 
secara signifIkan (p<0.05) daripada normal kecuali pada ALP. Kenyataan ini 
disokong oleh peru bahan berat badan dan berat relatif hati. SeE 
menunjukkan kesan penumpasan sel-sel kanser yang lebih baik daripada 
Glycyrrhizin pada kepekatan yang dikaji. Tambahan pula, tidak ada bukti 
yang menunjukkan kesan sampingan seE terhadap sel-sel normal. 
Kepekatan Glycyrrhizin yang lebih tinggi ( 1 5  mg/100 m1 atau 0.0 1 5%) 
dipercayai boleh menumpaskan kejadian kanser dengan lebih efektif 
berbanding dengan 0.005%. 
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CHAPTER I 
INTRODUCTION 
Cancer remains a hugely expensive public health problem in the 
world, both in economic terms and in terms of the amount of human 
suffering it produces. The past two decades have witnessed an explosion in 
the understanding of the molecular basis of malignant disease and in the 
rapid application of basic research concepts to the clinical arenas of 
diagnosis. Cancer has been the second leading cause of death in the United 
States for decades. Although heart disease leads cancer by more than 300 
000 deaths per year, cardiovascular deaths are declining, a realization that 
had led some to project that cancer deaths will predominate by the tum of 
the century (Weiss, 1993). In Japan, cancer has become the greatest cause 
of mortality since 1981. It accounts for one-fourth of all deaths in the 
population (Fujiki et al. , 1992; Namiki, 1994). Malaysia's Ministry of Health 
(1995) has statistically reported that malignant neoplasm (45%) is the major 
cause of death in Government Hospitals, which is 2.5 times higher than the 
heart diseases (16%). 
Research data currently available support the position that close to 
about 80 - 90% of the forms of most human cancers are caused by exposure 
of individuals to environmental factors (Jensen & Madsen, 1988), which 
involved the three general classes of carcinogenic agents, i.e. radiations, 
viruses and chemicals, and combination thereof (Miller & Miller, 1981). 
1 
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These are mainly due to life-style factors, such as smoking and dietary 
habits. Cigarette smoking is a major risk factor in the development of cancer 
of the lung, uterine, cervix, bladder, pancreas and kidney (Daly, 1993). Diet, 
which provides both carcinogens and anticarcinogens, is likely to be another 
major risk factor for cancer development (Ames, 1983) by modulating the 
metabolism of chemical carcinogens and influencing the selective 
development and growth of initiated cells or latent tumours to yield gross 
tumours (Miller & Miller, 1981). Humans are exposed concomitantly or 
sequentially to several carcinogens at low doses (Hasegawa et al. , 1991). 
Other factors involved in human cancer development include hormones, 
drugs and chronic irritation (Wakabayashi et aI. , 1992). 
Cancer development is a complicated process consisting of many 
steps namely initiation, promotion and progression, with multiple gene 
alterations found in human cancers. Many ways to prevent development of 
cancer have been proposed such as avoiding exposure to environmental 
carcinogens as far as possible and also to isolate an effective 
chemopreventive compound (Wakabayashi et al. , 1992) by using nontoxic 
anticancer agents, so-called cancer chemoprevention (Fujiki et al. , 1992). 
Chemoprevention of cancer is a mean of cancer control in which the 
occurrence of this disease is prevented by the administration of one or 
several chemical compounds. Some are naturally occurring constituents of 
food; others are purely synthetic. Chemopreventive agents used must have 
3 
trivial or no toxicity and desirably effective in a variety of tissue sites 
(Wattenberg, 1992). Their common prop'erty is the ability to induce the 
activities of electrophile-detoxification systems (Davidson et ai., 1990) 
therefore, blocking one or more steps in the process of the carcinogenesis 
(Ito et al. , 1994). 
Although recent advances in cancer diagnosis as well as in cancer 
therapy are really remarkable, cancer mortality will not easily be reduced 
(Fujiki et al., 1992). Henderson et al. (1992) suggested that there should be 
an ongoing evaluation due to the continuing cancer burden and the 
relatively slow impact of proven cancer prevention and treatment strategies 
in reducing cancer mortality. It is important to identify safe and effective 
agents, which prevent the endogenous formation or enhance detoxification of 
carcinogens and/or inhibit tumour promotion and progression (Reddy & 
Rao, 1994). 
Over the centuries, no fewer than 3000 plant species have been used 
to treat cancer (Lewis & Elvin-Lewis, 1997). Many recent studies indicate 
that among most plants tea extracts has the most potent anticarcinogenic 
agents, thereby raising much interest not only in Japan but also in USA & 
China (Reddy & Rao, 1994). Body of evidence obtained from in vitro and 
animal studies concerning potentially protective effects of tea is compelling 
and encompasses several important mechanisms that suggest possible 
beneficial effects of tea and tea polyphenols at most stages of cancer 
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development (Dreosti et al. 1997). Tea becomes a product of great value and 
its popularity as a non-intoxicating drink was enhanced as the official 
beverage replacing wine. It has now grown to become a beverage which is 
consumed by more than half the population of the world for reasons not only 
of its pleasant taste and refreshing action, but also because it is considered 
to be an e1ixit for all ills (Wickremasinghe, 1993). Its beneficial effects are 
achieved with a dose of five to ten cups of tea per day. Each cup of green tea 
is equivalent to 40 mg of green tea extract (50%). Therefore the 
recommended daily use is between 0.2 - 0.4 g of green tea extract (Hara, 
1994). Subsequent to medicinal properties of tea, many new plants are 
introduced and studied to increase the discovery of natural product cancer 
chemotherapeutic agents (Suh et al. , 1995). 
In this study, the anticarcinogenic effect of Strobilanthes crispus crude 
extract (SCE) during rat hepatocarcinogenesis was investigated. Application 
of body weight profile, histological evaluation, and enzyme tumour markers 
results were used in this in vivo study. Concurrently, nutrient compositions 
of the plant related to cancer prevention were also evaluated. The 
significance and the outcome of this study could be associated with 
prognosis, which is very important in a medical treatment management. 
Although Strobilanthes crispus has already been used as antideuritic 
traditionally for many years but its nutritional composition has never been 
detennined. A recent research by Kusumoto et al. (1992) found that this 
plant is a potent relief drug possibly used for AIDS and leukemia diseases, 
but further research on hepatocarcinogenesis or other diseases has not been 
done. Therefore, the objectives of this study were: 
1) To evaluate the nutrient composition of Strobilanthes crispus inclusive 
of the proximate analysis, vitamin content, mineral content, 
antioxidant activity, as well as the content of various antinutritional 
factors (cathechin, tannin, caffeine and alkaloid) 
2) To determine the anticancer activity of crude water extract of 
Strobilanthes crispus on hepatocarcinogenesis in vivo by the 
measurements of the body weight, liver weight, histological 
examinations and enzyme tumour markers activity such as 
glutathione S-transferases (GST) , gamma-glutamyl transpeptidase 
(GGT), uridine diphosphoglucuronyl transferase (UDPGT) and alkaline 
phosphatase (ALP), as well as the glutathione (GSH) substrate 
3) To compare the anticancer activity of SCE with the commercial drug, 
glycyrrhizin (GL) , thereof evaluating the approximate picture and 
posibility of SCE in suppressing liver cancer. 
CHAPTER II 
LITERATURE REVIEW 
Cancer 
Cancer is a cellular phenomenon (Brock & Madigan, 1991) of rapid 
and uncontrolled formation of abnormal cells in the body (Lewis & Elvin­
Lewis, 1977). Most cells in matured animals, although alive, do not divide 
extensively, apparently because of the presence of growth-inhibiting factors, 
which prevent them from initiating cell division under a variety of 
pathological conditions. Under some conditions, growth inhibition is 
overcome and the cells begin to divide uncontrollably. This extensive cellular 
growth is so excessive that the animal body is virtually consumed by cancer 
cells and the animal dies. 
The development of cancer cells in many organs and tissues have 
altered growth requirements and continue to grow, piling up to form a small 
'focus of growth' or 'foci' (Brock & Madigan, 1991). This associates with the 
prior appearance of new focal cell populations that are considered to be 
preneoplastic or premalignant precursor lesions (Farber et al. , 1976). Lesions 
can be divided into 3 groups; Group A as the non-neoplastic such as freckles 
and other familiar consequences of over-exposure of skin to sunlight, Group 
B as the benign neoplasms or papillomas which as non-invasive, and Group 
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C as the malignant tumours; constitute the sole manisfestation of disease 
(Lawley, 1987). 
Avoidance or reduction of exposure to carcinogens and early diagnosis 
were the only hopes of reducing the incidence of cancer. Events that occur 
between exposure to carcinogens and the ultimate development or overt 
malignancy offer many opportunities for blocking or even reversing the 
neoplastic process (Talalay, 1992). 
Carcinogenesis 
Carcinogenesis is a study of the origin of cancer to determine the 
steps involved in conversion of normal cells to malignant cells (Marshall, 
1993). It is a complex and protracted multistage process (Talalay, 1992) 
divided into at least three stages; initiation, promotion and progression (Ito 
et aI. , 1983). Initiation is known as the subtreshold neoplastic state, 
promotion is where latent tumour cells were stimulated to proliferate to form 
visible tumours, and progression is known as the development of malignant 
tumours (Group C) from tissues bearing benign neoplasms (Group B) 
(Lawley, 1987). 
One of the most promising and important ways to decrease human 
cancer mortality is through chemoprevention; though ideal chemopreventors 
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have not yet been developed. Chemoprevention is the process of inhibiting, 
delaying or reversing the process of carcinogenesis (Sharma et al., 1994). 
Hepatocarcinogenesis 
The liver is often the first organ to be infected by metastasising 
cancer. Hepatocarcinogenesis or hepatocellular carcinoma or liver cancer is 
one of the most prevalent and deadly cancers worldwide (Kathryn et aI. , 
1997) which ranks seventeenth among cancers in order of frequency of 
occurrence. An increased risk for developing liver cancer is correlated with 
either virus infection or consumption of alcoholic beverages (Henderson et 
al. , 1992). 
The liver has been studied intensively as a site for cancer 
development since 1935. It has been extensively utilized many times with 
many carcinogens for morphological, physiological and biochemical analysis 
of carcinogenesis because of (a) its size and its susceptibility to the induction 
of cancer, (b) growing body of knowledge about its cell biology, biochemistry 
and cell pathology, and (c) because of the ability to manipulate its state of 
proliferation (Farber & Cameron, 1980). Furthermore, the liver was 
convenient for quantitative biochemical analysis because it was considered 
to be a mass of relatively homogenous parenchymal cells and these cells has 
various marker enzymes (Kitagawa, 1976). The liver of the adult rat ( 1 50 -
200 g and larger) is ordinarily a quiescent organ with respect to cell 
